Shares in Tandem Diabetes Care (NSDQ:TNDM) fell this week after the insulin pump maker topped sales expectations but missed earnings estimates on Wall Street with its second-quarter financial results.
The San Diego, Calif.-based company posted a net loss of -$59.4 million on sales of $34.1 million for the 3 months ended June 30, for sales growth of 60% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Tandem posts mixed Q2 results appeared first on MassDevice.
from MassDevice https://ift.tt/2LBTIHs
Cap comentari:
Publica un comentari a l'entrada